Responses
Regular and young investigator award abstracts
Combination immunotherapies
452 Combination treatment using KISIMATM protein-based cancer vaccine and systemic STING agonist results in profound modulation of tumor microenvironment and improved tumor control
Compose a Response to This Article
Other responses
No responses have been published for this article.
